Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease
Phase of Trial: Phase IV
Latest Information Update: 29 Jun 2017
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Acronyms J-GOLD
- Sponsors Eisai Co Ltd
- 15 Dec 2016 Status changed from active, no longer recruiting to completed.
- 20 Oct 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 30 Jun 2010 Additional trial location [Japan] identified as reported by ClinicalTrials.gov.